EULARERA | 合法醫療器材資訊網

由MYates著作·2016·被引用805次—Apositivebiopsyisstronglysupportiveofadiagnosisofvasculitisandwe...inthetreatmentofactive,'generalised'ANCAassociatedvasculitis)).56 ...

Background and rationale

In 2009 the European League Against Rheumatism (EULAR) published recommendations for managing primary small and medium vessel vasculitis which included the management of AAV.10 The publication of 1691 papers in the past 5 years on primary systemic vasculitis in internal medicine, rheumatology and nephrology journals, as well as the licensing of rituximab for AAV, make this an opportune time to update the recommendations with an AAV focus. This update was made in conjunction with the European Renal Association—European Dialysis and Transplant Association (ERA-EDTA).

This paper reassesses standard therapy, including the use of biological agents, the prognostic value of histopathology and management of long-term complications, integrating these into treatment algorithms.

Statements

The statements in this manuscript are terme...

Treatment of ANCA Vasculitis | 合法醫療器材資訊網

treatment of ANCA vasculitis | 合法醫療器材資訊網

由 K Jain 著作 · 2021 — Over the past two decades, considerable progress has been made in maintaining remission in patients with ANCA vasculitis using a variety of ... Read More

What Is ANCA Vasculitis? | 合法醫療器材資訊網

2021年5月20日 — Causes of ANCA vasculitis ... The biological mechanisms underpinning this autoimmune disease remain to be fully elucidated, but research points to ... Read More

ANCA Vasculitis | 合法醫療器材資訊網

How is ANCA vasculitis treated? — ANCA vasculitis is caused when ANCAs attack neutrophils. This causes the white blood cells to attack vessel walls, which ... Read More

Treatment of ANCA | 合法醫療器材資訊網

由 U Schönermarck 著作 · 2014 · 被引用 74 次 — Treatment is biphasic, consisting of induction of remission (3-6 months) for rapid control of disease activity and maintenance of remission (at ... Read More

associated vasculitis based on ANCA type | 合法醫療器材資訊網

由 S Unizony 著作 · 2016 · 被引用 166 次 — Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type. Ann Rheum Dis. Read More

Update on the management of ANCA | 合法醫療器材資訊網

2019年1月11日 — A randomized controlled trial has documented that rituximab given at a dose of 500 mg intravenously every six months following remission ... Read More

EULARERA | 合法醫療器材資訊網

由 M Yates 著作 · 2016 · 被引用 805 次 — A positive biopsy is strongly supportive of a diagnosis of vasculitis and we ... in the treatment of active, 'generalised' ANCA associated vasculitis)).56 ... Read More

ANCA Glomerulonephritis and Vasculitis | 合法醫療器材資訊網

由 JC Jennette 著作 · 2017 · 被引用 164 次 — For decades, conventional treatment of ANCA disease with major organ involvement has been with high-dose cyclophosphamide and glucocorticoids, ... Read More

Overview of the management of vasculitis in adults | 合法醫療器材資訊網

由 PA Merkel 著作 — Remission induction – The goal of initial treatment is to induce remission of the disease. Initial management usually involves use of medium to ... Read More

相關資訊整理